Zobrazeno 1 - 10
of 10
pro vyhledávání: '"H. Thompson Heaton"'
Autor:
H. Thompson Heaton, Michael R. Ringor, Robert A. Cormack, Peter J. Biggs, Tina L. Pike, Bruce R. Thomadsen, Habib Safigholi, Christopher Stacey, Frank Weigand, Jonathan N. Law, Jessica R. Hiatt, Sujatha Pai, Mark J. Rivard, Wenzheng Feng, Zoubir Ouhib, Randall W. Holt, Timothy J. Waldron, James C.H. Chu, Gene A. Cardarelli, Jeffery P. Limmer, Sushakumari Pillai, Barrett S. Caldwell
Publikováno v:
Medical physicsReferences. 47(4)
PURPOSE The purpose of this study was to provide guidance on quality management for electronic brachytherapy. MATERIALS AND METHODS The task group used the risk-assessment approach of Task Group 100 of the American Association of Physicists in Medici
Autor:
Zoubir Ouhib, Mark J. Rivard, Frank André Siebert, Larry A. DeWerd, H. Thompson Heaton, Ravinder Nath, T Rusch, Ali S. Meigooni, William A. Dezarn, Geoffrey S. Ibbott, Jack L.M. Venselaar
Publikováno v:
Medical Physics. 43:3178-3205
Although a multicenter, Phase III, prospective, randomized trial is the gold standard for evidence-based medicine, it is rarely used in the evaluation of innovative devices because of many practical and ethical reasons. It is usually sufficient to co
Autor:
Ravinder, Nath, Mark J, Rivard, Larry A, DeWerd, William A, Dezarn, H, Thompson Heaton, Geoffrey S, Ibbott, Ali S, Meigooni, Zoubir, Ouhib, Thomas W, Rusch, Frank-André, Siebert, Jack L M, Venselaar
Publikováno v:
Medical physics. 43(6)
Although a multicenter, Phase III, prospective, randomized trial is the gold standard for evidence-based medicine, it is rarely used in the evaluation of innovative devices because of many practical and ethical reasons. It is usually sufficient to co
Autor:
Bruce R. Thomadsen, Jeffery P. Masten, Orhan H. Suleiman, Zoubir Ouhib, H. Thompson Heaton, Manny Subramanian, Mary E. Napolitano, T. Tydings Robin, Chester S. Reft, Shirish K. Jani, Mark J. Rivard
Publikováno v:
Medical Physics. 37:2300-2311
Medical products (devices, drugs, or biologics) contain information in their labeling regarding the manner in which the manufacturer has determined that the products can be used in a safe and effective manner. The Food and Drug Administration (FDA) a
Autor:
Zoubir Ouhib, Mary E. Napolitano, Mark J. Rivard, Orhan H. Suleiman, Chester S. Reft, T. Tydings Robin, Jeffery P. Masten, Shirish Jani, Bruce R. Thomadsen, H. Thompson Heaton, Manny Subramanian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37808befa21fe1d517d2c676b5b82184
https://doi.org/10.37206/114
https://doi.org/10.37206/114
Publikováno v:
Radiation Protection Dosimetry.
Eight previous intercomparisons conducted since 1974 show, on average, a 5% under-response of TLDs calibrated with 137 Cs relative to those calibrated with 60 Co. As reported previously, a 9th international intercomparison involving 43 participants f
Autor:
Manny Subramanian, Mary E. Napolitano, Orhan H. Suleiman, H. Thompson Heaton, Zoubir Ouhib, Chester S. Reft, Shirish K. Jani, Jeffery P. Masten, Mark J. Rivard, Bruce R. Thomadsen
Publikováno v:
Brachytherapy. 7:172
From Introduction: "This report is a compilation of the MeV Total Neutron Cross Section data measured at the U.S. National Bureau of Standards."
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8f3ed496e490932702b53894d7e5e94
https://doi.org/10.6028/nbs.mono.138
https://doi.org/10.6028/nbs.mono.138
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.